Singh D, Vignat J, Lorenzoni V et al (2023) Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health 11:e197–e206

Article  CAS  PubMed  Google Scholar 

Cohen PA, Jhingran A, Oaknin A, Denny L (2019) Cervical cancer. Lancet 393:169–182

Article  PubMed  Google Scholar 

Tian X, Wang X, Cui Z et al (2021) A fifteen-gene classifier to predict neoadjuvant chemotherapy responses in patients with stage IB to IIB squamous cervical cancer. Adv Sci (Weinh) 8:2001978

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abu-Rustum NR, Yashar CM, Bean S et al (2020) NCCN guidelines insights: cervical cancer, version 1.2020. J Natl Compr Canc Netw 18:660–666

Article  PubMed  Google Scholar 

Dyer BA, Zamarin D, Eskandar RN, Mayadev JM (2019) Role of immunotherapy in the management of locally advanced and recurrent/metastatic cervical cancer. J Natl Compr Canc Netw 17:91–97

Article  CAS  PubMed  Google Scholar 

Pötter R, Tanderup K, Schmid MP, EMBRACE Collaborative Group et al (2021) MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): A multicentre prospective cohort study. Lancet Oncol 22:538–547

Article  PubMed  Google Scholar 

Morris M, Eifel PJ, Lu J et al (1999) Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer. N. Engl. J. Med 340:1137–1143

Article  CAS  PubMed  Google Scholar 

Vale C, Jakobsen A (2008) Reducing Uncertainties About the Effects of Chemoradiotherapy for Cervical Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 18 Randomized Trials. J. Clin. Oncol 26:5802–5812

Article  CAS  Google Scholar 

Huang Y, Gomaa A, Höfler D et al (2025) Principles of artificial intelligence in radiooncology. Strahlenther Onkol 201(3):210–235. https://doi.org/10.1007/s00066-024-02272-0

Article  PubMed  Google Scholar 

Luo W (2021) Predicting Cervical Cancer Outcomes: Statistics, Images, and Machine Learning. Front Artif Intell 4:627369. https://doi.org/10.3389/frai.2021.627369

Article  PubMed  PubMed Central  Google Scholar 

Jha AK, Mithun S, Sherkhane UB et al (2023) Systematic review and meta-analysis of prediction models used in cervical cancer. Artif Intell Med 139:102549. https://doi.org/10.1016/j.artmed.2023.102549

Article  PubMed  Google Scholar 

Winter WE, Maxwell GL, Tian C et al (2004) Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecologic Oncology Group Study. Gynecol Oncol 94(2):495–501. https://doi.org/10.1016/j.ygyno.2004.04.008

Article  CAS  PubMed  Google Scholar 

Grogan M, Thomas GM, Melamed I et al (1999) The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 86(8):1528–1536

Article  CAS  PubMed  Google Scholar 

Barkati M, Fortin I, Mileshkin L et al (2013) Hemoglobin level in cervical cancer: a surrogate for an infiltrative phenotype. Int J Gynecol Cancer 23(4):724–729. https://doi.org/10.1097/IGC.0b013e31828a0623

Article  PubMed  Google Scholar 

Fyles AW, Milosevic M, Pintilie M et al (2000) Anemia, hypoxia and transfusion in patients with cervix cancer: a review. Clin Transl Radiat Oncol 57(1):13–19. https://doi.org/10.1016/s0167-8140(00)00245-0

Article  CAS  PubMed  Google Scholar 

Bishop AJ, Allen PK, Klopp AH et al (2015) Relationship between low hemoglobin levels and outcomes after treatment with radiation or chemoradiation in patients with cervical cancer: has the impact of anemia been overstated? Adv Radiat Oncol 91(1):196–205. https://doi.org/10.1016/j.ijrobp.2014.09.023

Article  CAS  PubMed  Google Scholar 

Tavares-Murta BM, Mendonca MA, Duarte NL et al (2010) Systemic leukocyte alterations are associated with invasive uterine cervical cancer. Int J Gynecol Cancer 20(7):1154–1159. https://doi.org/10.1111/igc.0b013e3181ef8deb

Article  PubMed  Google Scholar 

Garcia-Arias A, Cetina L, Candelaria M, Robles E, Duenas-Gonzalez A (2007) The prognostic significance of leukocytosis in cervical cancer. Int J Gynecol Cancer 17(2):465–470. https://doi.org/10.1111/j.1525-1438.2007.00816.x

Article  CAS  PubMed  Google Scholar 

Mabuchi S, Matsumoto Y, Isohashi F et al (2011) Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer. Gynecol Oncol 122(1):25–32. https://doi.org/10.1016/j.ygyno.2011.03.037

Article  PubMed  Google Scholar 

Cho Y, Kim KH, Yoon HI, Kim GE, Kim YB (2016) Tumor-related leukocytosis is associated with poor radiation response and clinical outcome in uterine cervical cancer patients. Facts Views Vis Obgyn 27(11):2067–2074. https://doi.org/10.1093/annonc/mdw308

Article  CAS  PubMed  Google Scholar 

Koulis TA, Kornaga EN, Banerjee R et al (2017) Anemia, leukocytosis and thrombocytosis as prognostic factors in patients with cervical cancer treated with radical chemoradiotherapy: A retrospective cohort study. Clin. Transl. Radiat. Oncol 12:51–56

Google Scholar 

Holub K, Biete A (2019) Impact of systemic inflammation biomarkers on the survival outcomes of cervical cancer patients. Clin. Transl. Oncol 21:836–844

Article  CAS  PubMed  Google Scholar 

Elmali A, Guler OC, Demirhan B et al (2024) Long-term analysis of hematological parameters as predictors of recurrence patterns and treatment outcomes in cervical cancer patients undergoing definitive chemoradiotherapy. Strahlenther Onkol 200(11):949–957

Article  PubMed  PubMed Central  Google Scholar 

Mizunuma M, Yokoyama Y, Futagami M et al (2015) The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer. Int J Clin Oncol 20:989–996

Article  CAS  PubMed  Google Scholar 

Li YX, Chang JY, He MY, et al. (2021) Neutrophil-to-Lymphocyte Ratio (NLR) and Monocyte-to-Lymphocyte Ratio (MLR) Predict Clinical Outcome in Patients with Stage IIB Cervical Cancer. J. Oncol. 2939162

Ferioli M, Benini A, Malizia C et al (2023) Classical Prognostic Factors Predict Prognosis Better than Inflammatory Indices in Locally Advanced Cervical Cancer: Results of a Comprehensive Observational Study including Tumor‑, Patient-, and Treatment-Related Data (ESTHER Study). J. Pers. Med 13:1229

Article  PubMed  PubMed Central  Google Scholar 

Medici F, Ferioli M, Forlani L et al (2023) Decoding the Complexity of Systemic Inflammation Predictors in Locally Advanced Cervical Cancer, with Hemoglobin as the Hidden Key (the ESTHER Study). Cancers 15:5056

Article  CAS  PubMed  PubMed Central  Google Scholar 

Medici F, Ferioli M, Cammelli S et al (2024) Sarcopenic Obesity in Cervical Carcinoma: A Strong and Independent Prognostic Factor beyond the Conventional Predictors (ESTHER Study-AFRAID Project). Cancers 16:929

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mehmood M, Rizwan M, Gregus MlM, Abbas S (2021) Machine Learning Assisted Cervical Cancer Detection. Front Public Health 9:788376. https://doi.org/10.3389/fpubh.2021.788376

Article  PubMed  PubMed Central  Google Scholar 

Shakil R, Islam S, Akter B (2024) A precise machine learning model: Detecting cervical cancer using feature selection and explainable AI. J Pathol Inform 15:100398. https://doi.org/10.1016/j.jpi.2024.100398

Article  PubMed  PubMed Central  Google Scholar 

Ding D, Lang T, Zou D et al (2021) Machine learning-based prediction of survival prognosis in cervical cancer. BMC Bioinformatics 22(1):331. https://doi.org/10.1186/s12859-021-04261-x

Article  CAS  PubMed